A similar correlation was also observed in gastric cancer patients, where high DENND10 expression was significantly associated with poor overall survival (p = 0.006) and a short duration of time to first-progression (p = 0.0018) (Additional file 1: Figure S1B). This evidence concerns the gene DENND10 and gastric cancer.